Oncomine Focus Panel PDL1
Introduction to the Oncomine Focus Panel PDL1 Test
The Oncomine Focus Panel PDL1 test is a cutting-edge diagnostic tool designed to evaluate the expression of PDL1 in tumor tissues. This test plays a pivotal role in the field of oncology, particularly in guiding treatment decisions for patients diagnosed with certain types of cancer. By analyzing the PDL1 expression, healthcare professionals can determine the potential effectiveness of immunotherapy treatments, which have revolutionized cancer care.
What the Test Measures
This test specifically detects the presence and levels of PDL1, a protein that can inhibit the immune response against cancer cells. High levels of PDL1 expression in tumors may indicate that a patient could benefit from immune checkpoint inhibitors, a class of drugs that enhance the body’s immune response against cancer.
Who Should Consider This Test?
Patients who are diagnosed with cancers such as lung cancer, melanoma, and others where PDL1 expression is a relevant biomarker should consider this test. Symptoms may include unexplained weight loss, persistent cough, or changes in the skin. Additionally, individuals with risk factors such as a family history of cancer or exposure to carcinogens should discuss the test with their healthcare provider.
Benefits of Taking the Oncomine Focus Panel PDL1 Test
- Informs treatment decisions regarding immunotherapy options.
- Helps identify patients who may respond positively to targeted therapies.
- Provides crucial information for personalized cancer treatment plans.
- Enhances the understanding of tumor biology and its implications for therapy.
Understanding Your Results
Results from the Oncomine Focus Panel PDL1 test will indicate the level of PDL1 expression in the tumor sample. High expression levels may suggest that immunotherapy could be an effective treatment option, while low levels may indicate the need for alternative therapies. It is essential to discuss your results with your healthcare provider to understand the implications for your treatment plan.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 1,050,000 NGN |
| Regular Price | 1,400,000 NGN |
Book the Oncomine Focus Panel PDL1 Test
To take the Oncomine Focus Panel PDL1 test, a doctor’s prescription is required. Please note that this test is not applicable for patients who have undergone surgery, are pregnant, or are planning to travel abroad. The turnaround time for results is approximately 20-25 days. For further inquiries or to schedule your test, please contact us at +2348077798758.
